Cite
APA Citation
Beyerlin, K., Jimenez, R., Zangardi, M., Fell, G. G., Edmonds, C., Johnson, A., Bossuyt, V., Specht, M., Mulvey, T. M., Moy, B., Ellisen, L. W., Isakoff, S. J., Bardia, A., & Spring, L. M. (2021). the adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US population. Journal of oncology pharmacy practice, 27, 1883–1890. http://access.bl.uk/ark:/81055/vdc_100144049059.0x00001e